Continuous remission of single-mode therapy with pembrolizumab plus chemotherapy in locally advanced hypopharyngeal carcinoma: a case report
Hypopharyngeal carcinoma, one of the common malignant tumors of the head and neck, is associated with high tumor aggressiveness, early cervical lymph node metastasis, and a poor prognosis. Neoadjuvant immunotherapy has been gradually introduced to treat locally advanced head and neck squamous cell c...
Saved in:
| Main Authors: | Guoning Yu, Jianqiao He, Yingna Gao, Xiaoqiong Shi, Yi Ma, Shicai Chen, Hongliang Zheng, Minhui Zhu, Caiyun Zhang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-06-01
|
| Series: | Frontiers in Immunology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2025.1557565/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Excellent response of cetuximab plus chemotherapy after pembrolizumab monotherapy in metastatic hypopharyngeal cancer: A case report
by: Anh Tuan Pham, et al.
Published: (2025-03-01) -
A retrospective efficacy and safety study of pembrolizumab/cetuximab neoadjuvant therapy in locally advanced hypopharyngeal cancer
by: Guangnan Yao, et al.
Published: (2025-06-01) -
Surgical management of hypopharyngeal cancer (narrative review)
by: N. N. Radzhabova, et al.
Published: (2019-07-01) -
Indian clinical practice consensus guidelines for the management of locoregional hypopharyngeal cancer - Update 2023
by: HS Darling, et al.
Published: (2024-11-01) -
Efficacy and safety of nanoparticle albumin-bound paclitaxel plus cisplatin or nedaplatin plus tegafur/gimeracil/oteracil as induction chemotherapy regimen for hypopharyngeal cancer
by: Cailing Jiang, et al.
Published: (2025-02-01)